Page last updated: 2024-08-25

voriconazole and Candidiasis, Cutaneous

voriconazole has been researched along with Candidiasis, Cutaneous in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, X; Li, C; Liu, N; Sheng, C; Tu, J; Xu, D; Zhu, T1
Cutlan, JE; Geddes, ER; Hymes, SR; Polder, K; Torres-Cabala, CA1

Other Studies

2 other study(ies) available for voriconazole and Candidiasis, Cutaneous

ArticleYear
Lanosterol 14α-demethylase (CYP51)/histone deacetylase (HDAC) dual inhibitors for treatment of Candida tropicalis and Cryptococcus neoformans infections.
    European journal of medicinal chemistry, 2021, Oct-05, Volume: 221

    Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Candida tropicalis; Candidiasis, Cutaneous; Cryptococcosis; Cryptococcus neoformans; Cytochrome P450 Family 51; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Histone Deacetylase Inhibitors; Histone Deacetylases; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship

2021
Ulcerated plaque under a ruby ring in an immunosuppressed patient.
    Dermatology online journal, 2010, Aug-15, Volume: 16, Issue:8

    Topics: Adenine Nucleotides; Aged; Antineoplastic Agents; Arabinonucleosides; Candida; Candidiasis, Cutaneous; Clofarabine; Cytarabine; Dermatologic Agents; Dermatomycoses; Fusarium; Humans; Immunocompromised Host; Itraconazole; Jewelry; Leukemia, Myeloid, Acute; Male; Pyrimidines; Skin Ulcer; Treatment Outcome; Triazoles; Voriconazole

2010